Literature DB >> 21976626

Radiation protection in fixed PET/CT facilities--design and operation.

D J Peet1, R Morton, M Hussein, K Alsafi, N Spyrou.   

Abstract

We describe the design of a fixed positron emission tomography (PET)/CT facility and the use of a simulated instantaneous dose-rate plot to visually highlight areas of potentially high radiation exposure. We also illustrate the practical implementation of basic radiation protection principles based on the use of distance and shielding and the minimisation of time spent in hot areas. Staff whole body doses for 4 years are presented with results of an optimisation study analysing the dose arising from the different phases within each study using direct reading dosemeters. The total whole body dose for all staff for each patient fell from 9.5 μSv in the first full year of operation to 4.8 µSv in 2008. The maximum dose to an individual member of staff per patient decreased over the same period from 3.2 to 0.9 µSv. The optimisation study showed that the highest dose was recorded during the injection phase.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21976626      PMCID: PMC3479878          DOI: 10.1259/bjr/32969351

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  8 in total

1.  Radionuclide and radiation protection data handbook 2nd edition (2002).

Authors:  D Delacroix; J P Guerre; P Leblanc; C Hickman
Journal:  Radiat Prot Dosimetry       Date:  2002       Impact factor: 0.972

2.  Radiation dose to PET technologists and strategies to lower occupational exposure.

Authors:  Fiona O Roberts; Dishan H Gunawardana; Kunthi Pathmaraj; Anthony Wallace; Paul L U; Tian Mi; Sam U Berlangieri; Graeme J O'Keefe; Chris C Rowe; Andrew M Scott
Journal:  J Nucl Med Technol       Date:  2005-03

Review 3.  The contribution of PET/CT to improved patient management.

Authors:  P J Ell
Journal:  Br J Radiol       Date:  2006-01       Impact factor: 3.039

4.  Radiation dose rates from patients undergoing PET: implications for technologists and waiting areas.

Authors:  N A Benatar; B F Cronin; M J O'Doherty
Journal:  Eur J Nucl Med       Date:  2000-05

5.  Radiation dose to technicians per nuclear medicine procedure: comparison between technetium-99m, gallium-67, and iodine-131 radiotracers and fluorine-18 fluorodeoxyglucose.

Authors:  C Chiesa; V De Sanctis; F Crippa; M Schiavini; C E Fraigola; A Bogni; C Pascali; D Decise; R Marchesini; E Bombardieri
Journal:  Eur J Nucl Med       Date:  1997-11

6.  Technologist radiation exposure in routine clinical practice with 18F-FDG PET.

Authors:  Benjamin Guillet; Pierre Quentin; Serge Waultier; Marc Bourrelly; Pascale Pisano; Olivier Mundler
Journal:  J Nucl Med Technol       Date:  2005-09

7.  Patient self-attenuation and technologist dose in positron emission tomography.

Authors:  Benjamin W Zeff; Michael V Yester
Journal:  Med Phys       Date:  2005-04       Impact factor: 4.071

8.  AAPM Task Group 108: PET and PET/CT shielding requirements.

Authors:  Mark T Madsen; Jon A Anderson; James R Halama; Jeff Kleck; Douglas J Simpkin; John R Votaw; Richard E Wendt; Lawrence E Williams; Michael V Yester
Journal:  Med Phys       Date:  2006-01       Impact factor: 4.071

  8 in total
  3 in total

1.  Effective and equivalent dose minimization for personnel in PET procedures: how far are we from the goal?

Authors:  M Lecchi; S Malaspina; A Del Sole
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-12       Impact factor: 9.236

2.  Radiation safety audit of a high volume Nuclear Medicine Department.

Authors:  Ashish Kumar Jha; Abhijith Mohan Singh; Bhakti Shetye; Sneha Shah; Archi Agrawal; Nilendu Chandrakant Purandare; Priya Monteiro; Venkatesh Rangarajan
Journal:  Indian J Nucl Med       Date:  2014-10

3.  Determination of a reliable assessment for occupational eye lens dose in nuclear medicine.

Authors:  Noriaki Miyaji; Kenta Miwa; Takashi Iimori; Kei Wagatsuma; Hiroyuki Tsushima; Noriyo Yokotsuka; Taisuke Murata; Tetsuharu Kasahara; Takashi Terauchi
Journal:  J Appl Clin Med Phys       Date:  2022-07-01       Impact factor: 2.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.